newsfilter
← Latest News
PR Newswire·

POMDOCTOR LIMITED Announces Strategic Upgrade, Focusing on "AI + Medical-Grade Smart Wearables" to Build a New Ecosystem for Full-Cycle Chronic Disease Management

POM
  • Pomdoctor Limited (NASDAQ: POM) announced a strategic upgrade focusing on AI, medical-grade smart wearables, & full-cycle chronic disease management.
  • The company plans to accelerate R&D & scenario-based implementation to build a closed-loop ecosystem integrating hardware, data, algorithms, & services.
  • The global chronic disease management market is projected to grow from USD 6.9 billion in 2025 to USD 18.8 billion by 2034 with an 11.7% CAGR.
  • China's market is driven by an aging population & approximately 180 million people living with chronic conditions.
  • Traditional outpatient management faces challenges including fragmented monitoring, delayed intervention, & low patient adherence.
  • The upgrade focuses on developing medical-grade smart wearables for accurate physiological data collection on conditions like diabetes & cardiovascular disease.
  • An AI-powered intelligent management system will be built to support risk monitoring, treatment planning, & doctor-patient collaboration.
  • A closed-loop service system will integrate hardware & AI with the existing internet hospital platform, pharmaceutical supply chain, & service infrastructure.
  • Strategic advantages include a strong medical compliance foundation, collaborative R&D capabilities, & benefits as a U.S.-listed company.
  • Chairman & CEO Zhenyang Shi emphasized the commitment to medical compliance, evidence-based medicine, & patient-centered care.
  • Pomdoctor ranks sixth in China's internet hospital market based on contracted doctors according to Frost & Sullivan data from 2022.